(Reuters) – The reigning NBA champion Boston Celtics have agreed to a $6.1 billion sale to a group headed by private equity firm Symphony Technology Group co-founder William Chisholm, the team said on Thursday. The sale, which is still pending approval from the NBA Board of Governors, would break the record for most expensive sports …
NBA-Reigning champion Celtics agree to record-breaking $6.1 billion sale Read More »
By David Lawder WASHINGTON (Reuters) – The tech startup executive charged by the Trump administration with reviewing the Internal Revenue Service’s technology modernization program said on Thursday that he has canceled contracts worth about $1.5 billion from the tax agency’s budget. Sam Corcos, founder and CEO of health technology firm Levels, and a member of …
Trump DOGE executive claims $1.5 billion savings from IRS technology budget Read More »
By Jonathan Allen NEW YORK (Reuters) – A deadline is looming for Columbia University to respond to nine demands on tightening restrictions on campus protests that U.S. President Donald Trump’s administration says are preconditions for opening talks on restoring $400 million in suspended federal funding. Among the unusual demands, the administration wants the New York …
Columbia up against Trump deadline for meeting demands over campus protests Read More »
By Kanishka Singh -A New Mexico jury found a failed Republican candidate for the state House of Representatives guilty on all counts related to a series of drive-by shootings at the homes of Democratic officials in Albuquerque, prosecutors said on Thursday. Solomon Pena was convicted on 13 felony charges including three counts of solicitation to …
Failed New Mexico candidate found guilty in plot to shoot Democratic officials Read More »
By Kanishka Singh WASHINGTON (Reuters) – The University of California, Los Angeles, was sued on Thursday over a 2024 mob attack on pro-Palestinian protesters at the height of the U.S. campus protest movement against Israel’s war in Gaza, a court filing showed. WHY IT’S IMPORTANT In one of the most violent incidents from U.S. protests …
UCLA sued over 2024 mob attack on pro-Palestinian protesters Read More »
By Jack Queen and Tim Reid (Reuters) -A federal judge said on Thursday the Social Security Administration likely violated privacy laws by giving tech billionaire Elon Musk’s aides “unbridled access” to the data of millions of Americans, and ordered a halt to further record sharing. U.S. District Judge Ellen Lipton Hollander of Maryland said Musk’s …
Judge stops Musk’s team from ‘unbridled access’ to Social Security private data Read More »
By Nate Raymond (Reuters) – A U.S. judge has been cleared of alleged wrongdoing for going on CNN to speak out against threats made against members of the judiciary and respond to Donald Trump’s comments about the daughter of the judge who presided over the New York case in which the now-president was convicted last …
US judge who criticized Trump attacks on judiciary cleared of ethics complaints Read More »
(This March 18 story has been refiled to add Fidel Castro’s full name in paragraph 10) WASHINGTON (Reuters) – Thousands of pages of digital documents related to the 1963 assassination of President John F. Kennedy are now available for historians, conspiracy theorists and the merely curious, following orders from U.S. President Donald Trump. The president, shortly …
On Trump’s orders, thousands of JFK assassination documents newly public Read More »
(Reuters) -A panel of immunization experts that advises the U.S. Centers for Disease Control and Prevention will convene in April after a previous meeting was postponed, a spokesman for the Department of Health and Human Services said in an email on Thursday. The Advisory Committee on Immunization Practices had been set to meet in February, …
US vaccine advisory meeting rescheduled for April Read More »
By Bhanvi Satija and Sneha S K (Reuters) -U.S. Food and Drug Administration approved Alnylam’s drug to treat a rare and deadly heart disease on Thursday, allowing the entry of a new type of medicine in a market dominated by Pfizer’s blockbuster Vyndaqel. Alnylam is banking on the success of the drug, chemically called vutrisiran, to …
US FDA expands approval for Alnylam’s drug to treat rare heart disease Read More »
